Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Simple vinegar test could rival High-Tech scope for cervical cancer screening

NCT ID NCT07692919

Diagnosis Sponsor: Sohag University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 09, 2026 · Last updated Jul 10, 2026 · Updated 1 time

Summary

This study compares two ways to spot early warning signs of cervical cancer: a simple vinegar test (VIA) and a magnified exam (colposcopy). Researchers will check how well each method finds pre-cancerous changes in women aged 25 to 65 who have symptoms or abnormal Pap smears. The goal is to see if the low-cost vinegar test can be as reliable as the more expensive scope, which could make screening easier in places with fewer resources.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
acetic acid solution
What this could lead to
If VIA proves as accurate as colposcopy, it could offer a simpler, more accessible screening method for cervical pre-cancer in low-resource settings.
What could go wrong
This is a small, single-center study, and VIA may not match colposcopy's accuracy. Results may not apply broadly, and discomfort or minor complications are possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 200 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Aug 2026

An estimate. Start dates often move.

Expected to finish

Jun 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

outpatient clinic pateints

Ages

25 to 65 years

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age from 25 to 65 years. * Patient undergoing cervical cancer screening using VIA and colposcopy. * Women with symptoms such as white discharge, post-coital bleeding, and intermenstrual bleeding. * Women with the clinically unhealthy cervix (erosion, bleeding on touch, simple leukoplakia, keratinization) * Women with Pap smear showing dysplasia. Exclusion Criteria: * • Pregnant women (if VIA or colposcopy is contraindicated). * Women with obvious invasive cervical cancer diagnosed previously. * Women who refuse to provide informed consent or are unable to cooperate with the examination. * Women having active vaginal bleeding. * Any past treatment for cervical lesions.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cervical intraepithelial neoplasia (CIN) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

cervical intraepithelial neoplasia cervicitis dysplasia of cervix

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cervical intraepithelial neoplasia (CIN) Cervicitis

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.